Home > > Middle East & Africa And Global Pharmaceutical Contract Development and Manufacturing Market- Size, Share, Growth Rate, and Forecast
The Middle East & Africa Pharmaceutical Contract Development and Manufacturing market was valued at $6,812.7 Million in 2023, and is projected to reach $10,915.8 Million by 2030 growing at a CAGR of 7.02% from 2024 to 2030. Pharmaceutical Manufacturing Services segment is expected to be the highest contributor to this market, with $5,760.3 Million in 2023, and is anticipated to reach $9,118.7 by 2030, registering a CAGR of 6.83%. Drug Development Services segment is anticipated to reach $800.2 Million by 2030 with the highest CAGR of 9.82%. Pharmaceutical Manufacturing Services and Biologics Manufacturing Services segments collectively expected to account for about 93.9% share of the Middle East & Africa Pharmaceutical Contract Development and Manufacturing market in 2023, with the former constituting around 84.6% share. Drug Development Services and Pharmaceutical Manufacturing Services segments are expected to witness significant growth rates at a CAGR of 9.82% and 6.83% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 90.7% in the overall Middle East & Africa Pharmaceutical Contract Development and Manufacturing market in 2023, and is anticipated to reach 90.9% by 2030. Service Pharmaceutical Manufacturing Services Biologics Manufacturing Services Drug Development Services End User Big Pharma Small & Mid-size Pharma Generic Pharmaceutical Companies Other End Users BY REGION North America US Canada Europe Germany France UK Italy Spain RoE Asia China Japan India RoAPAC Middle East & Africa Latin America MEA